Updated Advice for the Care ofPregnant Women
Dear Obstetric Shared Care GPs,
CONNECTING YOU WITH THE NEWS YOU NEED FOR
GP OBSTETRIC SHARED CARE
Welcome to Monday – the first day of November!
We are bringing you CPD activities you may like to squeeze in before the end of the year.
This newsletter is designed to give you a 3-5 minute hit to fire up the other 10,077 minutes of your week! I have also included an offering of freshly published research.
Stay up to date with the latest information by clicking on the links below.
CONTRACEPTIVE CONVERSATIONS WITH A POP OF PROGESTERONE
Join us in a relaxed environment in the beautiful Adelaide Hills listening to an experienced Presenter engage you for the night!
DON’T DELAY REGISTER NOW
Date: Tuesday 9th November 2021
Time: 6.30pm – 9.00pm – Registration from 5.45pm
Venue: Auchendarroch House, Mt Barker
Presenter: Dr Amy Moten
MBS WORKSHOP IN ADELAIDE
Since March 2020 there have been over 200 changes to the MBS creating an even more complex set of rules and regulations for new services such as GP Telehealth services and Telephone consultations.
The BFD MBS 2021 series provides up to date information and is ideal for seasoned GPs, Practice Owners, Practice Managers and Registrars.
Date: Thursday 11th November 2021
Time: 6.00pm – 10.00pm ACDT
Venue: Stamford Grand Adelaide Hotel
Presenter: Dr April Armstrong
CLICK HERE:FOR DETAILS
Obstetric Shared Care – On The Road
Save the Date
Date: Friday 19th November 2021
Time: 6.00pm – 9.00pm
Venue: McCracken Country Club, Victor Harbor
Exciting details available very soon!
REGISTRATION AVAILABLE FROM 8th NOVEMBER 2021
COMPLICATIONS IN PREGNANCY – TELOMERES PROJECT
Approximately 25% of births are the result of pregnancies complicated by pre-eclampsia, gestational diabetes mellitus, pre-term birth, or intrauterine growth restriction.
Offspring born from a pregnancy complication have up to a 6-fold higher risk of chronic diseases in adulthood, including stroke, coronary heart disease, and chronic kidney disease.
However, we do not know which children born from a complicated pregnancy are at increased risk of developing cardio-metabolic diseases.
CAN YOU HELP?
Can you help us establish if a need exists for a screening measure in children who were born from a complicated pregnancy?
Could you take part in a 20-minute interview exploring your opinion on blood test as a screening measure in children who were born from a complicated pregnancy?
Your input will help us provide the foundation to develop a screening method to identify at-risk children so that suitable interventions in childhood can be implemented to ameliorate future chronic disease risk.
CLICK HERE: FOR DETAILS TO PARTICIPATE
A gift card of $50 will be offered to GPs who participate in this study.
PRE-ECLAMPSIA AND FETAL GROWTH RESTRICTION
Talks on pre-sclampsia and fetal growth restriction
We hope that you enjoy them.
An update on emerging therapies for preeclampsia – Prof Stephen Tong
The benefits versus harm of detecting fetal growth restriction – Roshan Selvaratnam
Fetal growth restriction: from confusion to consensus – Prof Sue Walker
Listen to Shannon’s story – a patient’s experience
Password for all videos – Twilight
Slides are here in case you want to browse through them at a more leisurely pace.
If you listen to the video/s – please let Leanne at email@example.com so that your OSC CPD points can be allocated.
Use of metformin to prolong gestation in preterm pre-eclampsia:
randomised, double blind, placebo controlled trial.
This randomized placebo-controlled trial examined metformin to treat preterm pre-eclampsia.
- 180 women diagnosed with preterm preeclampsia between 26+0 – 31+6 weeks gestation were treated with 3g of oral metformin (extended release) or placebo daily until delivery.
- The primary outcome was prolongation of gestation.
- The median time from randomization to delivery was 17.7 days (IQR 5.4 – 29.4 days) for the metformin arm vs 10.1 days (IQR 3.3 – 24.1 days) for the placebo arm; median difference of 7.6 days (p-value 0.057).
- In a pre-specified analysis excluding women who stopped taking the trial drug (13 in the metformin group and 15 in the placebo group) the median time from randomization to delivery was 17.5 days (IQR 5.4 – 28.7 days) in the metformin arm vs 7.9 days (3.0 – 22.2 days) in the placebo arm; significant median difference of 9.6 days.
- In a further pre-specified analysis excluding women who reduced the dose of trial drug (34 in the metformin group and 11 in the placebo) the median time from randomization to delivery was 16.3 days (IQR 4.8 – 28.8 days) in the metformin arm vs 4.8 days (IQR 2.5 – 15.4 days) in the placebo arm; significant median difference of 11.5 days.
- Secondary composite maternal, fetal and neonatal outcomes did not differ between the metformin and placebo arms.
- Among exploratory outcomes, birthweight was non-significantly increased in the metformin arm compared with placebo (1620g vs 1510g) and the total length of admission to any neonatal unit was non-significantly reduced in the metformin arm compared with placebo (18 vs 30 days, median difference of 12 days).
- Women in the metformin arm, compared with the placebo arm, experienced more diarrhoea (33% vs 6%) and a non-significant increase in nausea (21% vs 11%). No serious adverse events related to the trial drug were recorded.
These findings suggest metformin may be associated with a clinically meaningful prolongation of gestation among women with preterm preeclampsia. Importantly, these findings also provide evidence that preterm preeclampsia is treatable. Given the borderline significance, further trials are needed to confirm these findings in a larger cohort before metformin is rolled out as a treatment for preterm preeclampsia.
Congential Syphilis Case Review
A report on outcomes with recommendations for prevention and management of future cases.
Latest Update from NALHN
Midwife Coordinator – Siobhan Lucas
Please CLICK HERE for Term 4 Planners for Parafield Gardens and CLICK HERE for Keithcott Farm, the community sites that the GP Obstetric Shared Care Midwife attends/undertakes booking visits. There are some great resources/groups for new parents to attend.
Other resources for your patients:
First Aid Refresher: CLICK HERE
Toilet Training Workshop: CLICK HERE
Baby Massage: CLICK HERE
Allied Health – Drop In and Chat: CLICK HERE
There is a GP Obstetric Shared Care evening clinic available at Keithcot Farm Children’s Centre, time 1700hrs.
This will give the option for working parents to attend their booking visit at a convenient time, reducing the need to take time off work.
Can you help us find out the ideal amount of iodine needed in pregnancy for baby’s brain development?
Please complete this form indicating whether you are interested in inviting your pregnant women who are less than 13 weeks into their pregnancy to take part in this research.
A $100 payment will be made to GPs who have a patient successfully recruited into the PoppiE Study
FAMILY OF ORIGIN FORM: CLICK HERE
SA PATHOLOGY – OMEGA 3 REQUEST FORM: CLICK HERE
GP Partners Australia is committed to building upon its strong foundations and achievements, strengthening its valued partnerships and future-proofing its services to the community, including providing strong advocacy, training, education and support for GPs and women participating in the GP Obstetric Shared Care Program, for years to come.
Thank you for continuing to support the GP Obstetric Shared Care Program.
Don’t forget to visit our GP Partners Australia website for further updates and resources www.gppaustralia.org.au
We trust this – and future updates – will be of help to you during these crazy times.
If you have any questions or require additional information please do not hesitate to contact the GP Obstetric Shared Care Program Manager – Leanne at firstname.lastname@example.org